Evolution News and Research

RSS

HER2 gastric cancer: Unraveling resistance at single-cell resolution

HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies.

16 Feb 2026

Aptar Pharma’s intranasal solutions power CastleVax Phase II clinical trials for next-gen COVID-19 vaccine

In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are being utilized in CastleVax’s Phase II clinical trial for CVAX-01, an intranasal COVID-19 vaccine candidate.

From Hanson Wade Group - 4th Nasal Formulation & Delivery Summit 16 Feb 2026

Whole-heart mapping captures arrhythmias in a single heartbeat

The UPV and Corify Care present the first whole-heart mapping technology that provides a comprehensive view of cardiac arrhythmias in a single heartbeat.

13 Feb 2026

Sjöberg Prize awarded to British scientist for pioneering tumor evolution research

This year's Sjöberg Prize of one million US dollars is awarded to a British cancer researcher who has provided fundamental knowledge about evolution in tumors.

12 Feb 2026

Global report highlights inequities in pediatric palliative care

Nearly all the world's 10.6 million children experiencing serious health-related suffering (SHS) live in low- and middle-income countries with little to no access to palliative care specialized care for their illness, according to a comprehensive new report published in The Lancet Child & Adolescent Health.

10 Feb 2026

Engineered enzyme enables fast and accurate RNA synthesis

From vaccines and diagnostics to emerging gene-based therapies, RNA molecules are now central to modern medicine.

9 Feb 2026

CRISPR gene-drive technology reverses antibiotic resistance in bacteria

Antibiotic resistance (AR) has steadily accelerated in recent years to become a global health crisis. As deadly bacteria evolve new ways to elude drug treatments for a variety of illnesses, a growing number of "superbugs" have emerged, ramping up estimates of more than 10 million worldwide deaths per year by 2050.

7 Feb 2026

Rapid malaria resistance evolution in Sudanese Coptic populations

The study published in PNAS sets out how, in just 1,500 years, the Copts have acquired a genetic variant that protects them from contracting malaria after mixing with other Sudanese populations.

6 Feb 2026

Reprogrammed neutrophils promote tumor growth

Predicting tumor progression is one of the major challenges in oncology. Scientists at the University of Geneva (UNIGE) and the Ludwig Institute for Cancer Research have discovered that neutrophils, a type of immune cell, undergo reprogramming when they come into contact with the tumor ecosystem and contribute to its progression.

5 Feb 2026

New card deck helps children manage stress and build resilience

A Case Western Reserve University professor has developed an innovative card deck designed to help children manage stress and build emotional resilience in today's challenging world.

4 Feb 2026

Five mutation patterns shape how cancers evade immunity

Cancer cells carry thousands of mutations, but not all mutations are created equal. Some make tumors highly visible to the immune system, while others help cancers hide.

4 Feb 2026

Burn injuries may have driven key human evolutionary traits

Humans' exposure to high temperature burn injuries may have played an important role in our evolutionary development, shaping how our bodies heal, fight infection, and sometimes fail under extreme injury, according to new research.

4 Feb 2026

Implantable immune scaffold predicts type 1 diabetes weeks before symptoms

The study highlights a presymptomatic phase in type 1 diabetes progression, using immune niches to track immune changes before blood sugar abnormalities.

4 Feb 2026

New score predicts complications after mild traumatic brain injury

A study led by researchers at the Institute for Research in Biomedicine of Lleida (IRBLleida), the University of Lleida (UdL), the Universitat Oberta de Catalunya (UOC) and Arnau de Vilanova University Hospital (HUAV) has developed and internally validated a clinical prediction model called the Goliat score, which can be used by emergency services to estimate the risk of acute complications in patients suffering from minor and moderate traumatic brain injuries (TBIs).

3 Feb 2026

Bacteria repurpose viral injection systems to target diverse cells

New study shows how bacteria adapted a virus-derived injection system to recognize and attach to many different types of cells.

2 Feb 2026

Bat viruses in Indochina Peninsula reveal viral diversity, PEDV origins, and spillover risks

Bats, critical reservoirs of viruses with significant cross-species spillover risks, have long been understudied in the Indochina Peninsula.

2 Feb 2026

ERC Proof of Concept grant supports promising CRISPR-based cancer treatment research

Microbiologist John van der Oost of Wageningen University & Research (WUR) has received an ERC Proof of Concept grant to further develop a promising CRISPR-based approach to cancer treatment. With funding of €150,000, he and researcher Christian Südfeld will spend the next eighteen months working on a method to kill cancer cells from within, while sparing healthy cells as much as possible.

30 Jan 2026

AI uncovers evolution of genetic control elements in mammalian cerebellum

Artificial intelligence allows tracing the evolution of genetic control elements in the developing mammalian cerebellum.

30 Jan 2026

Research uncovers trade-offs in aging muscle stem cell functionality

Aging muscles heal more slowly after injury - a frustrating reality familiar to many older adults.

30 Jan 2026

NIH grant advances Indigenous-driven genomic research in Alaska and Oklahoma

A transdisciplinary team led by Southcentral Foundation, a Tribal healthcare organization in Anchorage, Alaska, has been awarded a competitive grant from the National Institutes of Health. Jessica Blanchard, Ph.D., senior research scientist at the University of Oklahoma's Center for Applied Social Research, is a key collaborator on the project, representing the continuation of a longstanding partnership between OU and Southcentral Foundation.

27 Jan 2026